Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
A Study in Non Small Cell Lung Cancer
| Conditions: | Non Small Cell Lung Cancer |
| Start Date: | December 1, 2010 |
| Phase: | Phase I|Phase II |
| Status: | Not yet recruiting |
| NCT ID: | NCT01139775 |
| Study Type: | Interventional |
| Intervention: | Drug: Pemetrexed|Drug: Cisplatin|Drug: LY2603618 |
| Study Design: | Allocation: Randomized|Control: Active Control|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Eli Lilly and Company |
| Ages: | Adult|Senior |
| Enrollment: | 64 |
| Funded By: | Industry |
| First Received: | June 1, 2010 |
| End Date: | March 1, 2014 |
| Last Updated: | December 6, 2010 |
| Last Verified: | December 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
